1-(1,3-苯并二氧戊环-4-基)甲胺 | 182634-34-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并间二氧杂环戊烯类
• 中文名称: 1-(1,3-苯并二氧戊环-4-基)甲胺
• 中文别名: 苯并[D][1,3]二氧杂环戊烯-4-基甲胺；苯并[D][1,3]二氧代-4-甲胺；5-[5-反-(4-反-乙基环己基)-1,3-二噁烷-2-基]-1,2,3-三氟杂苯并醇
• 英文名称: 1,3-benzodioxol-4-ylmethanamine
• 英文别名: 2,3-methylenedioxybenzylamine；Benzo[d][1,3]dioxol-4-ylmethanamine
• CAS: 182634-34-0
• 化学式: C₈H₉NO₂
• mdl: MFCD11858181
• 分子量: 151.165
• InChiKey: WOSCKVGRNOPBKO-UHFFFAOYSA-N

物化性质

• 沸点：
  85 °C(Press: 0.4 Torr)
• 密度：
  1.253±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  44.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2932999099
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2H-1,3-Benzodioxol-4-ylmethanamine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2H-1,3-Benzodioxol-4-ylmethanamine
CAS number: 182634-34-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H9NO2
Molecular weight: 151.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-(1,3-苯并二氧戊环-4-基)甲胺 在 palladium diacetate sodium tetrahydroborate 、 copper diacetate 、 air 、 sodium sulfate 作用下， 以 甲醇 、 二氯甲烷 、 甲苯 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 反应 5.0h， 生成 2-(3-nitrobenzyl)-4,5-(methylenedioxy)isoindolin-1-one
  参考文献：
  名称：

  Pd（OAc）2催化胺的羰基化

  摘要：

  无膦的催化体系[Pd（OAc）2 -Cu（OAc）2-空气]在沸腾的甲苯中，在CO气体（1个大气压）下引发了胺的底物特异性羰基化。通过伯胺的羰基化获得对称的N，N'-二烷基脲。N，N，N′-三烷基脲通过向上述反应容器中添加仲胺而选择性地形成。仲胺不产生四烷基脲。但是，在烷基链上带有苯基的二烷基胺，例如N-对单烷基化的苄胺或苯乙胺衍生物进行直接的芳族羰基化反应，得到五元或六元的苯并内酰胺。在羰基化反应中，发现Pd（II）与邻位钯的间位取代基之间的螯合效应或位阻以及羰基化之前形成的环钯的产物的环大小可产生良好的位点选择性并提高反应速率。相反，具有羟基的ω-芳基烷基胺的羰基化既不产生脲也没有苯并内酰胺，而是平稳地产生1，3-恶唑烷酮。在所用条件下，胺的盐酸盐也进行羰基化，得到相应的酰胺。该程序使得可以制备氨基酸酯的脲和实际收率的N-烷基氨基甲酸酯。

  DOI：

  10.1021/jo060612n
• 作为产物：
  描述：

  2,3-(亚甲二氧基)苯甲醛 在 palladium on activated charcoal 、 盐酸羟胺 、 甲酸铵 、 sodium hydroxide 作用下， 以 甲醇 、 水 为溶剂， 反应 49.0h， 生成 1-(1,3-苯并二氧戊环-4-基)甲胺
  参考文献：
  名称：

  Modulators of protease activated receptors

  摘要：

  本发明提供了式（I）的新化合物，包括这些化合物的药物组合物以及使用这些化合物作为生物研究工具或治疗代理或药物用于代谢综合征、肥胖、2型糖尿病、纤维化和心血管疾病等疗法的方法，无论是单独使用还是与其他治疗方式结合使用。

  公开号：

  US09868763B2

文献信息

• Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
  申请人：Tachdjian Catherine

  公开号：US20050084506A1

  公开（公告）日：2005-04-21

  The present invention relates to the discovery that certain non-naturally occurring, non-peptide amide compounds and amide derivatives, such as oxalamides, ureas, and acrylamides, are useful flavor or taste modifiers, such as a flavoring or flavoring agents and flavor or taste enhancer, more particularly, savory (the “umami” taste of monosodium glutamate) or sweet taste modifiers,—savory or sweet flavoring agents and savory or sweet flavor enhancers, for food, beverages, and other comestible or orally administered medicinal products or compositions.

  本发明涉及发现，某些非天然存在的非肽酰胺化合物和酰胺衍生物，如草酰胺、脲和丙烯酰胺，可用作风味或口味调节剂，例如风味或调味剂和风味或口味增强剂，更具体地说，是用于食品、饮料和其他可食用或口服药品或组合物的风味或口味调节剂，包括鲜味（味精的“鲜味”）或甜味调节剂，鲜味或甜味调味剂以及鲜味或甜味增强剂。
• ARYL FLUOROETHYL UREAS ACTING AS ALPHA 2 ADRENERGIC AGENTS
  申请人：Chow Ken

  公开号：US20080194650A1

  公开（公告）日：2008-08-14

  The invention provides well-defined aryl fluoroethyl ureas that are useful as selective alpha 2 adrenergic agonists. As such, the compounds described herein are useful in treating a wide variety of disorders associated with modulation of alpha 2 adrenergic receptors.

  本发明提供明确定义的芳基氟代乙基脲，用作选择性的α2肾上腺素能激动剂。因此，所述化合物可用于治疗与α2肾上腺素能受体调节相关的一系列疾病。
• [EN] IMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES AS PRC2 INHIBITORS FOR TREATING CANCER<br/>[FR] DÉRIVÉS D'IMIDAZO [1,2-C]PYRIMIDINE UTILISÉS COMME INHIBITEURS DE PRC2 POUR LE TRAITEMENT DU CANCER
  申请人：MIRATI THERAPEUTICS INC

  公开号：WO2020247475A1

  公开（公告）日：2020-12-10

  Disclosed are compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, disclosed are compounds of Formula (I) and pharmaceutical compositions thereof, and methods of using the compounds and pharmaceutical compositions in, for example, methods of treating cancer.

  揭示了抑制Polycomb Repressive Complex 2 (PRC2)活性的化合物。具体来说，揭示了Formula (I)的化合物及其药物组成物，以及使用这些化合物和药物组成物的方法，例如用于治疗癌症的方法。
• Rhodium-Catalyzed Regio- and Enantioselective Allylic Amination of Racemic 1,2-Disubstituted Allylic Phosphates
  作者：Wen-Bin Xu、Minghe Sun、Mouhai Shu、Changkun Li

  DOI：10.1021/jacs.1c04016

  日期：2021.6.9

  Alkynylphosphines are rarely used as ligands in asymmetric metal catalysis. We synthesized a series of chiral bis(oxazoline)alkynylphosphine ligands and used them in Rh-catalyzed highly regio- and enantioselective allylic amination reactions of 1,2-disubstituted allylic phosphates. Chiral 1,2-disubstituted allylic amines were synthesized in up to 95% yield with >20:1 branched/linear (b/l) ratio and

  炔基膦很少用作不对称金属催化中的配体。我们合成了一系列手性双（恶唑啉）炔基膦配体，并将它们用于 Rh 催化的 1,2-二取代烯丙基磷酸酯的高度区域和对映选择性烯丙基胺化反应。手性 1,2-二取代烯丙基胺的合成产率高达 95%，支链/线性 (b/l) 比 >20:1 ，外消旋 1,2-二取代烯丙基前体的ee为99% 。双（恶唑啉）炔基膦配体中 P 原子上空间较小的线性炔基是满足引入大体积 2-R' 基团的新要求的关键。
• Pyrimidine derivatives as ghrelin receptor modulators
  申请人：Kosogof Christi

  公开号：US20050070712A1

  公开（公告）日：2005-03-31

  The present invention is related to compounds of formula (I), or a therapeutically suitable salt or prodrug thereof, the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders regulated by ghrelin including anorexia, cancer cachexia, eating disorders, age-related decline in body composition, weight gain, obesity, and diabetes mellitus.

  本发明涉及式(I)的化合物，或者其治疗上适宜的盐或前药，该化合物的制备、含有该化合物的组合物以及在预防或治疗由生长激素释放素调节的疾病中使用该化合物，包括厌食症、癌症恶病质、进食障碍、与年龄相关的身体组成下降、体重增加、肥胖和糖尿病。